Moderna says Covid-19 vaccine 94.5% effective

Moderna on Monday announced its experimental vaccine against Covid-19 was shown to be 94.5 percent effective according to early results from a clinical trial with more than 30,000 participants.

“This positive interim analysis from our Phase 3 study has given us the first clinical validation that our vaccine can prevent COVID-19 disease, including severe disease,” said Stephane Bancel, Moderna’s CEO.

Follow our socials Whatsapp, Facebook, Instagram, Twitter, and Google News.

MORE FROM AFRIUPDATE

Firm denies wrongdoing over COVID-19 test project

October 25, 2023

Medical row in France over unauthorised Covid trial

May 28, 2023

Prepare for a disease even much deadlier than COVID – WHO chief warns

May 23, 2023

Concerns over new, highly contagious COVID-19 sub-variant

April 20, 2023